Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. (AQST) Stock Overview
Explore Aquestive Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
410.1M
P/E Ratio
-6.01
EPS (TTM)
$-0.78
ROE
1.96%
AQST Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Aquestive Therapeutics, Inc. (AQST) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.50.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.01 and a market capitalization of 410.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.